Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Türedi, SÜLEYMAN; Gündüz, ABDÜLKADİR; Menteşe, AHMET; Dasdibi, Bengu; Karahan, SÜLEYMAN; Sahin, AYNUR; Tuten, Gamze; Kopuz, Muge; Alver, AHMET

doi:10.1016/j.resuscitation.2009.06.007

Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Copy For Citation

Türedi S., Gündüz A., Menteşe A., Dasdibi B., Karahan S. C., Sahin A., ...More

RESUSCITATION, vol.80, no.9, pp.994-999, 2009 (SCI-Expanded)

Publication Type: Article / Article
Volume: 80 Issue: 9
Publication Date: 2009
Doi Number: 10.1016/j.resuscitation.2009.06.007
Journal Name: RESUSCITATION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.994-999
Keywords: Ischemia-modified albumin, Ischemia, Cardiac arrest, Cardiopulmonary resuscitation, Oxidative stress, NEURON-SPECIFIC ENOLASE, PULMONARY-EMBOLISM, OXIDATIVE STRESS, SERUM, DIAGNOSIS, HYPOTHERMIA, PREDICTION, PROTEIN, S-100, COMA
Karadeniz Technical University Affiliated: Yes

Abstract

Background: Early and accurate prediction of survival to hospital discharge following resuscitation after cardiac arrest (CA) is a major challenge. Our aim was to investigate the levels of ischemia-modified albumin (IMA) and malondialdehyde (MDA) in CA patients and whether IMA levels are valuable early marker of post-cardiopulmonary resuscitation prognosis in CA patients.